These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 4968077)

  • 1. Immunization against Brucella with killed vaccines. II. Immunizing activity of killed Brucella vaccines in guinea pigs.
    Rasooly G; Olitzki AL; Sulitzeanu D
    Isr J Med Sci; 1967; 3(6):814-21. PubMed ID: 4968077
    [No Abstract]   [Full Text] [Related]  

  • 2. Resistance of normal or immunized guinea pigs against a subcutaneous challenge of Brucella abortus.
    Pardon P; Marly J
    Ann Rech Vet; 1978; 9(3):419-25. PubMed ID: 107845
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunization with recombinant Brucella species outer membrane protein Omp16 or Omp19 in adjuvant induces specific CD4+ and CD8+ T cells as well as systemic and oral protection against Brucella abortus infection.
    Pasquevich KA; Estein SM; García Samartino C; Zwerdling A; Coria LM; Barrionuevo P; Fossati CA; Giambartolomei GH; Cassataro J
    Infect Immun; 2009 Jan; 77(1):436-45. PubMed ID: 18981242
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Evaluation of antibrucellosis vaccines using guinea pigs].
    Le Garrec Y; Pilet C; Garrido-Calderon N
    Dev Biol Stand; 1976; 31():301-7. PubMed ID: 816686
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Optimal immunizing doses of vaccinal strains of Brucella].
    Shumilov KV
    Veterinariia; 1979 Aug; (8):31-4. PubMed ID: 113924
    [No Abstract]   [Full Text] [Related]  

  • 6. Immunogenic activity of a cell wall fraction extracted from Brucella abortus in guinea-pigs.
    Bosseray N; Plommet M; Dubray G
    Ann Microbiol (Paris); 1978; 129 B(4):571-9. PubMed ID: 112900
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunization against Brucella with killed vaccines. Immunizing activity in mice of Brucella cell walls and of fractions derived from them.
    Rasooly G; Olitzki AL; Sulitzeanu D
    Isr J Med Sci; 1966; 2(5):569-84. PubMed ID: 5970644
    [No Abstract]   [Full Text] [Related]  

  • 8. Brucella abortus vaccines: comparison of protection provided by immunopotentiated 45/20 bacterins and live strain 19 vaccine in guinea pigs.
    Woodard LF; Toone NM; Jasman RL
    Am J Vet Res; 1981 Nov; 42(11):1959-62. PubMed ID: 6802042
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Effect of simultaneous inoculation of B. abortus strain 19 and foot-and-mouth disease vaccines on immunity against brucellosis in the guinea pig].
    García-Carrillo C
    Rev Asoc Argent Microbiol; 1978; 10(1):1-7. PubMed ID: 210482
    [No Abstract]   [Full Text] [Related]  

  • 10. [Immunological mechanism of a chemical antigen of Brucella M104].
    Lu XZ
    Zhonghua Liu Xing Bing Xue Za Zhi; 1983 Jun; 4(3):153-6. PubMed ID: 6414715
    [No Abstract]   [Full Text] [Related]  

  • 11. Experimental study on the protective antigen derived from the vaccine strain Brucella abortus BA-19.
    Milerová J
    Prog Immunobiol Stand; 1967; 3():269-74. PubMed ID: 4985512
    [No Abstract]   [Full Text] [Related]  

  • 12. Protection of BALB/c mice against Brucella abortus 544 challenge by vaccination with bacterioferritin or P39 recombinant proteins with CpG oligodeoxynucleotides as adjuvant.
    Al-Mariri A; Tibor A; Mertens P; De Bolle X; Michel P; Godefroid J; Walravens K; Letesson JJ
    Infect Immun; 2001 Aug; 69(8):4816-22. PubMed ID: 11447155
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Vaccination with Brucella recombinant DnaK and SurA proteins induces protection against Brucella abortus infection in BALB/c mice.
    Delpino MV; Estein SM; Fossati CA; Baldi PC; Cassataro J
    Vaccine; 2007 Sep; 25(37-38):6721-9. PubMed ID: 17686554
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Immunogenic properties of the cellular components of Brucella].
    Baeva AA; Taran IF
    Zh Mikrobiol Epidemiol Immunobiol; 1975 Aug; (8):71-6. PubMed ID: 812309
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Properties of an immunogenic fraction from Brucella abortus 45/20.
    Corbel MJ; Redwood DW
    Dev Biol Stand; 1984; 56():159-68. PubMed ID: 6436092
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Venezuelan field trials of vaccines against brucellosis in swine.
    Lord VR; Cherwonogrodzky JW; Schurig GG; Lord RD; Marcano MJ; Meléndez GE
    Am J Vet Res; 1998 May; 59(5):546-51. PubMed ID: 9582954
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of aflatoxin on serum proteins, complement activity, and the antibody response to Brucella abortus in guinea pigs.
    Thurston JR; Deyoe BL; Baetz AL; Richard JL; Booth GD
    Am J Vet Res; 1974 Aug; 35(8):1097-100. PubMed ID: 4211951
    [No Abstract]   [Full Text] [Related]  

  • 18. Increases of efficacy as vaccine against Brucella abortus infection in mice by simultaneous inoculation with avirulent smooth bvrS/bvrR and rough wbkA mutants.
    Grilló MJ; Manterola L; de Miguel MJ; Muñoz PM; Blasco JM; Moriyón I; López-Goñi I
    Vaccine; 2006 Apr; 24(15):2910-6. PubMed ID: 16439039
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunization against Brucella with killed baccines. 3. Experiments in mice.
    Rasooly G; Boros DL; Gerichter C
    Isr J Med Sci; 1968; 4(2):246-51. PubMed ID: 4967767
    [No Abstract]   [Full Text] [Related]  

  • 20. Recombinant Brucella abortus proteins that induce proliferation and gamma-interferon secretion by CD4+ T cells from Brucella-vaccinated mice and delayed-type hypersensitivity in sensitized guinea pigs.
    Oliveira SC; Harms JS; Banai M; Splitter GA
    Cell Immunol; 1996 Sep; 172(2):262-8. PubMed ID: 8964089
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.